Sabra Health Care REIT, Inc. (NASDAQ:SBRA) is Leisure Capital Management's 3rd Largest Position

Leisure Capital Management raised its position in Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Free Report) by 12.2% during the third quarter, according to its most recent filing with the SEC. The institutional investor owned 531,012 shares of the real estate investment trust's stock after purchasing an additional 57,591 shares during the period. Sabra Health Care REIT accounts for approximately 4.2% of Leisure Capital Management's portfolio, making the stock its 3rd biggest holding. Leisure Capital Management owned approximately 0.23% of Sabra Health Care REIT worth $9,882,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Family Firm Inc. purchased a new position in shares of Sabra Health Care REIT during the 2nd quarter worth $26,000. Newbridge Financial Services Group Inc. purchased a new position in shares of Sabra Health Care REIT during the 4th quarter worth $56,000. GAMMA Investing LLC raised its holdings in shares of Sabra Health Care REIT by 40.0% during the 2nd quarter. GAMMA Investing LLC now owns 3,682 shares of the real estate investment trust's stock worth $57,000 after acquiring an additional 1,052 shares during the period. Future Financial Wealth Managment LLC purchased a new position in shares of Sabra Health Care REIT during the 1st quarter worth $89,000. Finally, Point72 Hong Kong Ltd purchased a new position in shares of Sabra Health Care REIT during the 2nd quarter worth $117,000. Hedge funds and other institutional investors own 99.40% of the company's stock.

Sabra Health Care REIT Stock Up 1.2 %

SBRA stock traded up $0.21 during trading on Wednesday, hitting $18.43. 1,060,732 shares of the company's stock were exchanged, compared to its average volume of 2,031,062. The company has a current ratio of 4.27, a quick ratio of 4.27 and a debt-to-equity ratio of 0.89. Sabra Health Care REIT, Inc. has a 52-week low of $12.83 and a 52-week high of $19.32. The business has a 50-day moving average price of $17.56 and a two-hundred day moving average price of $15.77. The stock has a market capitalization of $4.32 billion, a price-to-earnings ratio of 86.76, a PEG ratio of 2.55 and a beta of 1.26.

Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) last issued its quarterly earnings data on Wednesday, August 7th. The real estate investment trust reported $0.10 earnings per share for the quarter, missing analysts' consensus estimates of $0.34 by ($0.24). Sabra Health Care REIT had a net margin of 7.83% and a return on equity of 1.87%. The firm had revenue of $176.14 million during the quarter, compared to analysts' expectations of $166.54 million. During the same quarter in the prior year, the firm posted $0.34 EPS. Sabra Health Care REIT's quarterly revenue was up 9.3% compared to the same quarter last year. As a group, equities research analysts expect that Sabra Health Care REIT, Inc. will post 1.38 EPS for the current year.

Sabra Health Care REIT Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, August 30th. Shareholders of record on Monday, August 19th were paid a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 6.51%. The ex-dividend date was Monday, August 19th. Sabra Health Care REIT's dividend payout ratio is currently 571.43%.

Wall Street Analyst Weigh In

Several analysts recently issued reports on SBRA shares. Scotiabank boosted their price objective on shares of Sabra Health Care REIT from $17.00 to $18.00 and gave the company a "sector perform" rating in a report on Friday, October 11th. Citigroup raised Sabra Health Care REIT from a "neutral" rating to a "buy" rating and boosted their price objective for the stock from $17.00 to $20.00 in a research report on Friday, September 13th. Wells Fargo & Company raised Sabra Health Care REIT from an "equal weight" rating to an "overweight" rating and boosted their price objective for the stock from $16.00 to $20.00 in a research report on Tuesday, October 1st. Finally, Truist Financial boosted their price objective on Sabra Health Care REIT from $16.00 to $18.00 and gave the stock a "buy" rating in a research report on Wednesday, September 4th. Two equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $18.11.

About Sabra Health Care REIT

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing - Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.